Brief: Kimia Biosciences Gets Permission To Manufacture And Market 'Fimasartan Potassium Trihydrate API'
23/07/2020 08:15
July 23 (Reuters) - Kimia Biosciences Ltd KIMI.BO :
* KIMIA BIOSCIENCES - GOT PERMISSION TO MANUFACTURING AND
MARKETING OF NEW ACTIVE PHARMACEUTICAL INGREDIENT 'FIMASARTAN
POTASSIUM TRIHYDRATE API'
Source text for Eikon: ID:nBSE7B3vCn
Further company coverage: KIMI.BO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kimia Biosciences
See all newsBrief: Kimia Biosciences Ltd Says Naveen Sharma Resigns As CFO
Brief: Kimia Biosciences Appoints Naveen Sharma As CFO
Brief: Kimia Biosciences Pradip Kumar Sharma Resigns as Chief Financial Officer
Brief: Kimia Biosciences Says Rakesh Chetani Resigns As CFO
Brief: Kimia Biosciences Gets Order Worth $200,000